SI
PDLI

SII Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

SII Investments’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-11,121
Closed -$86K – 417
2013
Q2 		$86K Buy
+11,121
New +$86.7K 0.02% 367

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

SII Investments's PDLI Position: Q3 2013 in Review

SII Investments sold out of PDL BioPharma, Inc. (PDLI) in Q3 2013, closing a stake of 11,121 shares — an estimated $86K sold.

SII Investments first reported a position in PDLI in Q2 2013 and held it in 1 quarter. The position peaked at $86K in Q2 2013. 212 funds tracked by Wall St. Rank hold PDLI as of Q3 2013.

  • SII Investments reported no remaining PDL BioPharma, Inc. position as of Q3 2013 after selling out during the quarter.
  • SII Investments sold 11,121 PDL BioPharma, Inc. shares in Q3 2013, an estimated $86K.
  • SII Investments first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 1 quarter.
  • SII Investments's PDL BioPharma, Inc. position peaked at $86K in Q2 2013.
  • 212 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2013.

Based on SII Investments's 13F filing for Q3 2013, filed 14 Nov 2013.